XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total $ 797,519 $ 2,917,341 $ 2,618,313 $ 12,587,707
Research and development services (over-time)        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total 59,900 135,622 202,634 349,587
Clinical laboratory testing services (point-in-time)        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total 13,150 1,521,315 31,710 7,596,748
Clinical laboratory testing services (over-time)        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total 311,580 653,382 960,740 3,033,346
Supply chain        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total 194,031 242,826 936,777 682,799
Large Scale DNA Production        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total $ 218,858 271,884 477,010 653,015
Asset marking        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total   $ 92,312 $ 9,442 $ 272,212